Abstracts from the Joint Meeting of the International Society for NeuroVirology (ISNV) and the Society on NeuroImmune Pharmacology (SNIP) April 10-14, 2018, Chicago, Illinois, USA

Journal of Neuroimmune Pharmacology, Mar 2018

A PDF file should load here. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a PDF plug-in installed and enabled in your browser.

Alternatively, you can download the file locally and open with any standalone PDF reader:

https://link.springer.com/content/pdf/10.1007%2Fs11481-018-9786-5.pdf

Abstracts from the Joint Meeting of the International Society for NeuroVirology (ISNV) and the Society on NeuroImmune Pharmacology (SNIP) April 10-14, 2018, Chicago, Illinois, USA

Journal of Neuroimmune Pharmacology Abstracts from the Joint Meeting of the International Society for NeuroVirology (ISNV) and the Society on NeuroImmune Pharmacology (SNIP) April 10-14, 2018, Chicago, Illinois, USA Neil Sullivan 0 1 2 3 6 8 11 14 17 19 21 22 25 26 28 31 35 40 43 46 48 51 53 55 60 68 70 73 76 79 84 89 92 94 95 97 100 101 104 106 109 112 113 114 117 121 127 130 Will Dampier 0 1 2 3 6 8 11 14 17 19 21 22 25 26 28 31 35 40 43 46 48 51 53 55 60 68 70 73 76 79 84 89 92 94 95 97 100 101 104 106 109 112 113 114 117 121 127 130 Greg Homan 0 1 2 3 6 8 11 14 17 19 21 22 25 26 28 31 35 40 43 46 48 51 53 55 60 68 70 73 76 79 84 89 92 94 95 97 100 101 104 106 109 112 113 114 117 121 127 130 Vanessa Pirrone 0 1 2 3 6 8 11 14 17 19 21 22 25 26 28 31 35 40 43 46 48 51 53 55 60 68 70 73 76 79 84 89 92 94 95 97 100 101 104 106 109 112 113 114 117 121 127 130 Katie Kercher 0 1 2 3 6 8 11 14 17 19 21 22 25 26 28 31 35 40 43 46 48 51 53 55 60 68 70 73 76 79 84 89 92 94 95 97 100 101 104 106 109 112 113 114 117 121 127 130 Shendra Passic 0 1 2 3 6 8 11 14 17 19 21 22 25 26 28 31 35 40 43 46 48 51 53 55 60 68 70 73 76 79 84 89 92 94 95 97 100 101 104 106 109 112 113 114 117 121 127 130 Jean Williams 0 1 2 3 6 8 11 14 17 19 21 22 25 26 28 31 35 40 43 46 48 51 53 55 60 68 70 73 76 79 84 89 92 94 95 97 100 101 104 106 109 112 113 114 117 121 127 130 Michael Nonnemacher 0 1 2 3 6 8 11 14 17 19 21 22 25 26 28 31 35 40 43 46 48 51 53 55 60 68 70 73 76 79 84 89 92 94 95 97 100 101 104 106 109 112 113 114 117 121 127 130 Brian Wigdahl (corresponding author: aga 0 1 2 3 6 8 11 14 17 19 21 22 25 26 28 31 35 40 43 46 48 51 53 55 60 68 70 73 76 79 84 89 92 94 95 97 100 101 104 106 109 112 113 114 117 121 127 130 @drexel.edu) 0 1 2 3 6 8 11 14 17 19 21 22 25 26 28 31 35 40 43 46 48 51 53 55 60 68 70 73 76 79 84 89 92 94 95 97 100 101 104 106 109 112 113 114 117 121 127 130 0 Department of Microbiology and Immunology and Center for Molecular Virology and Translational Neuroscience, Institute for Molecular Medicine and Infectious Disease, Drexel University College of Medicine 1 P2 AURKA activation acidifies endolysosomes in neurons and may inhibit Alzheimer's disease pathogenesis Zahra Afghah , Jonathan Geiger, Xuesong Chen ( 2 P1 TIMBD modulates neurotransmission and improves HIV-1 Tat-associated anxiety-like behavior and memory deficits in Tat-transgenic mice Fatma Abdalla, Hari K. Bhat , Anil Kumar ( 3 P9 Development of a Sustained Release Long-Acting Darunavir Prodrug Nanoparticle Mary Banoub , Aditya Bade, JoEllyn McMillan, Benson Edagwa, Howard Gendelman ( 4 Department of Pharmacology, Georgetown University , Washington, DC , USA 5 Department of Neuroscience, Georgetown University , Washington, DC , USA 6 P8 The role of neuronal cytoskeleton in NeuroAIDS Valeria Avdoshina 7 Applied Proteomics and Molecular Medicine, George Mason University 8 P12 Virosomes: An interplay between Virus and Exosomes from infected cells Robert Barclay 9 Systems Biosciences , SBI 10 Laboratory of Molecular Virology, School of Systems Biology, George Mason University 11 P11 Exosomes from Uninfected Cells Activate HIV-1 Transcription Robert Barclay 12 Department of Immunology, Herbert Wertheim College of Medicine, Florida International University , USA 13 Ceres Nanosciences Inc 14 P17 CRISPR/Cas9 system as an agent for eradication of Polyomavirus JC infection Anna Bellizzi 15 Institute of Translational Pharmacology, National Research Council , Rome 16 University of Sassari - Dep of Biomedical Sciences 17 P16 Inhibition of HSV-1 replication by a gene editing strategy Anna Bellizzi 18 Center for Neurovirology, Dep of Neuroscience - Temple University Lewis Katz School of Medicine 19 P15 Eradication of HIV-1 from in vitro infected primary myeloid and brain cells using Tat-inducible CRISPR/Cas9 system Ramona Bella , Won-Bin Young, Alison Kearns, Pietro Mancuso, Rahsan Sariyer, Chen Chen, Dominika Nawrat, Kamel Khalili, Rafal Kaminski ( 20 Dep of Public Health and Infectious Diseases, Sapienza University of Rome, Laboratory Affiliated to Istituto Pasteur Italia - Fondazione Cenci Bolognetti , Rome 21 P24 Alcohol-Induced Inflammation Primes the Brain to Augment Methinduced Dopaminergic Deficits Amanda Blaker 22 P23 Varicella zoster virus alters expression of cell adhesion proteins in human perineurial cells via IL-6 Anna Blackmon , USA 23 Indiana University School of Medicine , USA 24 University of Toledo College of Medicine 25 P22 Rhesus Macaque Model of Zika and SIV/HIV Co-infection Mehdi Bidokhti 26 P28 New findings regarding the HIV-1 transgenic rat Rosemarie M Booze 27 Institute of NeuroImmune Pharmacology, Seton Hall University 28 P27 PERK Haplotype Function in HIV-Associated Neurocognitive Disorders Sarah Bond 29 Director, Institute of NeuroImmune Pharmacology, Professor of Biological Sciences/Neuroscience, Seton Hall University 30 Department of Psychology, University of South Carolina , USA 31 P26 Dysregulation of Sonic Hedgehog Pathway and Pe (...truncated)


This is a preview of a remote PDF: https://link.springer.com/content/pdf/10.1007%2Fs11481-018-9786-5.pdf

Abstracts from the Joint Meeting of the International Society for NeuroVirology (ISNV) and the Society on NeuroImmune Pharmacology (SNIP) April 10-14, 2018, Chicago, Illinois, USA, Journal of Neuroimmune Pharmacology, 2018, pp. 1-102, Volume 13, Issue 1, DOI: 10.1007/s11481-018-9786-5